US 9422352
PTD-SMAD7 therapeutics
granted A61KA61K38/00A61K38/162
Quick answer
US patent 9422352 (PTD-SMAD7 therapeutics) held by The Regents of the University of Colorado, a Body Corporate expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00, A61K38/162, A61K38/18, A61K48/005